Hasil Pencarian  ::  Simpan CSV :: Kembali

Hasil Pencarian

Ditemukan 185989 dokumen yang sesuai dengan query
cover
Heru Widyawarman
"[ABSTRAK
Pendahuluan Osteosarkoma adalah tumor ganas tulang paling sering ditemukan di RS Cipto Mangunkusumo (RSCM). Penatalaksanaan osteosarkoma dengan limb-salvage surgery (LSS) makin berkembang disamping tindakan amputasi. Penelitian ini bertujuan untuk mengetahui perbandingan luaran hasil LSS dan amputasi pada pasien osteosarkoma di RSCM.
Metode Studi ini menggunakan desain kohort retrospektif pada pasien osteosarkoma periode tahun 1995-2014 di RSCM. Dilakukan evaluasi angka kesintasan, rekurensi lokal, metastasis, komplikasi, skor fungsional menurut Musculoskeletal Tumor Society Scoring system (MSTS) pada pasien yang dilakukan LSS dan amputasi. Metode Kaplan-Meier digunakan untuk mendeskripsikan kesintasan, sintasan bebas rekurensi lokal antara LSS dan amputasi. Hubungan karakteristik pasien dianalisis dengan uji log rank. Uji Kai kuadrat, Eksak Fischer dan Mann-Whitney U digunakan untuk menganalisis hubungan antara skor MSTS dan karakteristik pasien, angka rekurensi, metastasis serta komplikasi. Untuk melihat pengaruh katakteristik terhadap sintasan dilakukan analisis regresi Cox dan uji Wald serta analisis multivariat backward stepwise.
Temuan Penelitian dan Diskusi Kesintasan 5 tahun pasien osteosarkoma 14,6%. Kesintasan 5 tahun LSS 34,8%, kesintasan 5 tahun amputasi 15,9%. Kesintasan bebas rekurensi lokal 5 tahun untuk LSS 96,2% dan untuk amputasi 86,5%. Kesintasan dipengaruhi metastasis, tipe operasi dan ukuran tumor. Metastasis merupakan faktor paling berpengaruh berdasarkan analisis multivariat. Metastasis terbanyak ditemukan di paru. Gejala awal dan staging Enneking mempengaruhi metastasis (p=0,02 dan 0,007). Infeksi adalah komplikasi tersering. Tipe biopsi FNAB memberi komplikasi yang paling sedikit. LSS memberi skor fungsional yang lebih tinggi (83,3%) daripada amputasi (61,7%). Pasien dengan rekurensi lokal cenderung mempunyai skor fungsional buruk (p=0,023).
Kesimpulan Kesintasan paling tinggi pada pasien osteosarkoma RSCM yang dilakukan LSS. Luaran fungsional dengan skor MSTS baik (83,3%) didapatkan pada pasien yang dilakukan LSS dan bebas rekurensi lokal. Skor MSTS buruk dijumpai pada pasien amputasi dengan rekurensi lokal, komplikasi dan metastasis.

ABSTRACT
Introduction Osteosarcoma is the most common malignant bone tumor seen in Cipto Mangunkusumo Hospital (CMH). Treatment for osteosarcoma includes limb-salvage surgery (LSS), and it is increasingly more frequently performed compared to amputation. This study aims to analyze the outcome of LSS compared to amputation for osteosarcoma patients in CMH.
Methods This is a retrospective cohort study to review osteosarcoma patients during 1995-2014 period in CMH. Analysis was performed on survival rate, local recurrence, metastasis, complication, and functional score according to Musculoskeletal Tumor Scoring System (MSTS) for patients underwent LSS or amputation. Kaplan-Meier method was used to determine survival rate, and disease-free survival rate between LSS and amputation. Log-rank analysis was used to determine relationship between patients characteristic. Chi-Square, Exact-Fischer, and Mann-Whitney U tests were used to analyze the correlation between MSTS score and patient characteristics, rate of recurrence, metastasis, and complication. To determine the influence of patient characteristics to survival, Cox regression analysis, Wald Test and backward stepwise multivariate analysis were performed.
Results and discussion 5-year survival rate osteosarcoma patients was 14.6%, 5-year survival rate for LSS was 34.8% compared to 15.9% for amputation. Disease-free survival for LSS was 96,2%, while amputation was 86,5%. Survival were influenced by metastasis, type of surgical intervention, and tumor size. According to multivariate analysis, survival was most influenced by metastasis. Metastasis were found predominantly in lungs. Initial symptoms and Enneking stage were correlated to metastasis (p=0.02 and 0.007, respectively). Infection was the most common complication. FNAB gave the least complication compared to other types of biopsy. LSS gave the highest functional score (83.3%) compared to amputation (61.7%). Patients with local recurrence tend to have poor functional score (p=0.023).
Conclusion The highest survival rate for osteosarcoma patients in CMH was found on patients who underwent LSS. Good functional outcome according to MSTS score (83.3%) were found on patients who underwent LSS and free of local recurrence. Poor MSTS score were seen on patients undergone amputation, patients who had had local recurrence, complication and metastasis, Introduction Osteosarcoma is the most common malignant bone tumor seen in Cipto Mangunkusumo Hospital (CMH). Treatment for osteosarcoma includes limb-salvage surgery (LSS), and it is increasingly more frequently performed compared to amputation. This study aims to analyze the outcome of LSS compared to amputation for osteosarcoma patients in CMH.
Methods This is a retrospective cohort study to review osteosarcoma patients during 1995-2014 period in CMH. Analysis was performed on survival rate, local recurrence, metastasis, complication, and functional score according to Musculoskeletal Tumor Scoring System (MSTS) for patients underwent LSS or amputation. Kaplan-Meier method was used to determine survival rate, and disease-free survival rate between LSS and amputation. Log-rank analysis was used to determine relationship between patients characteristic. Chi-Square, Exact-Fischer, and Mann-Whitney U tests were used to analyze the correlation between MSTS score and patient characteristics, rate of recurrence, metastasis, and complication. To determine the influence of patient characteristics to survival, Cox regression analysis, Wald Test and backward stepwise multivariate analysis were performed.
Results and discussion 5-year survival rate osteosarcoma patients was 14.6%, 5-year survival rate for LSS was 34.8% compared to 15.9% for amputation. Disease-free survival for LSS was 96,2%, while amputation was 86,5%. Survival were influenced by metastasis, type of surgical intervention, and tumor size. According to multivariate analysis, survival was most influenced by metastasis. Metastasis were found predominantly in lungs. Initial symptoms and Enneking stage were correlated to metastasis (p=0.02 and 0.007, respectively). Infection was the most common complication. FNAB gave the least complication compared to other types of biopsy. LSS gave the highest functional score (83.3%) compared to amputation (61.7%). Patients with local recurrence tend to have poor functional score (p=0.023).
Conclusion The highest survival rate for osteosarcoma patients in CMH was found on patients who underwent LSS. Good functional outcome according to MSTS score (83.3%) were found on patients who underwent LSS and free of local recurrence. Poor MSTS score were seen on patients undergone amputation, patients who had had local recurrence, complication and metastasis]"
2015
T-Pdf
UI - Tesis Membership  Universitas Indonesia Library
cover
Astuti Pitarini
"ABSTRAK
Pendahuluan Penggunaan megaprostesis sebagai pilihan dalam manajemen LSS
memberikan harapan baru bagi pasien tumor tulang di Indonesia. Namun, sampai
saat ini belum ada data hasil luaran dari tata laksana ini.
Metode Penelitian ini merupakan prospektif observational pada 34 pasien tumor
tulang di RS Cipto Mangunkusumo pada tahun 2011-2015. Diagnosis ditegakkan
melalui Clinical Pathological Conference. Evaluasi pascaoperasi dilakukan pada
bulan ke-3, 6, 9, 12, 24, 36, dan 48 dengan menggunakan skoring dari MSTS.
Luaran onkologi dievaluasi dengan adanya rekurensi dan metastasis jauh.
Komplikasi berupa infeksi, dislokasi, cedera saraf dan pembuluh darah, serta
gangguan mekanisme ekstensor juga dievaluasi.
Hasil Dua orang ahli bedah muskuloskeletal onkologi melakukan operasi LSS dan
rekonstruksi dengan megaprostesis. Dua pasien dieksklusi karena keputusan
intraoperatif untuk memakai non modular endoprostesis. Kehilangan darah
intraoperatif memiliki median (RAK) 890,0 (700,0?1200,0) ml. Skor MSTS
sebagian besar pasien menunjukkan kategori baik dan sangat baik, yaitu 67.9%
baik pada MSTS 6 bulan, 79,2% baik pada MSTS 9 bulan, 63.4% sangat baik
pada 12 bulan, 90% sangat baik pada 24 bulan dan 100% sangat baik pada MSTS
36 bulan. Terdapat hubungan bermakna antara karakteristik pasien yaitu jenis
tumor (p=0,001), usia (p=0,039), jenis kelamin (p=0,049), dan hasil laboratorium
ALP (p=0,031) dengan luaran fungsional MSTS 3 bulan. Terdapat hubungan
bermakna antara karakteristik pasien yaitu perdarahan intraoperatif (p=0,013) dan
ALP (p=0,009) dengan mortalitas; dan juga antara tumor tulang yang menjalani
rekonstruksi jaringan lunak ekstensif dengan komplikasi (p=0,019) namun antara
lokasi tumor dan komplikasi tidak terdapat hubungan bermakna.
Kesimpulan Luaran fungsional pada pasien yang dilakukan rekonstruksi
megaprostesis adalah baik dan sangat baik sehingga dapat menjadi tatalaksana
pilihan bagi pasien tumor tulang yang akan menjalani LSS. Luaran onkologi pada
pasien yang dilakukan prosedur LSS baik dengan rendahnya rekurensi lokal, metastasi, dan komplikasi. ABSTRACT
Introduction Advancement in bone tumor management has elaborated surgeon?s
choice of treatment not merely sentenced the patients into a limb ablation.
Likewise, patients with bone tumors, regardless its malignant nature and limited
survival time, had an equal privileges to opt for LSS to experience a better quality
of life. In this study, we manage to evaluate the functional and oncologic outcome
of lower extremity bone tumors following a LSS using megaprosthesis.
Methods Thirty-four patients with lower extremity bone tumors were
prospectively reviewed between 2011 and 2015 in a tertiary referral general
hospital. All patients were managed through a Clinical Pathology Conference.
Functional outcome was evaluated using MSTS score and follow up was recorded
at 3, 6, 12 months; and 2, 3, 4 years.
Results Two orthopedic musculoskeletal oncologic surgeons were performing the
surgeries. Two patients were excluded because the final instruments used were
not a modular type. The final result of functional score was good to excellent with
67.9% good at 6 months, 79,2% good at 9 months, 63.4% excellent at 12 months,
90% excellent at 24 months and 100% excellent at 36 months. Complications
occurred and varied. A statistical significant result was found between age
(p=0,001), age (p=0,039), gender (p=0,049), SAP (p=0,031) and 3 months
functional outcome; between intraoperative blood loss (p=0,013) and mortality,
as well as SAP with mortality (p=0,009); between tumor that underwent extensive
soft tissue reconstruction procedure and complication (p=0,019).
Conclusion Megaprosthesis reconstruction in bone tumors gives a good and
excellent result, which provides orthopaedic oncologic surgeons a rationalization
to make a selective decision-making in tumor cases regardless its survival and
tumor type. Oncologic outcome as well gave out good result with low incidence of far metastasis and local recurrence.;Introduction Advancement in bone tumor management has elaborated surgeon?s
choice of treatment not merely sentenced the patients into a limb ablation.
Likewise, patients with bone tumors, regardless its malignant nature and limited
survival time, had an equal privileges to opt for LSS to experience a better quality
of life. In this study, we manage to evaluate the functional and oncologic outcome
of lower extremity bone tumors following a LSS using megaprosthesis.
Methods Thirty-four patients with lower extremity bone tumors were
prospectively reviewed between 2011 and 2015 in a tertiary referral general
hospital. All patients were managed through a Clinical Pathology Conference.
Functional outcome was evaluated using MSTS score and follow up was recorded
at 3, 6, 12 months; and 2, 3, 4 years.
Results Two orthopedic musculoskeletal oncologic surgeons were performing the
surgeries. Two patients were excluded because the final instruments used were
not a modular type. The final result of functional score was good to excellent with
67.9% good at 6 months, 79,2% good at 9 months, 63.4% excellent at 12 months,
90% excellent at 24 months and 100% excellent at 36 months. Complications
occurred and varied. A statistical significant result was found between age
(p=0,001), age (p=0,039), gender (p=0,049), SAP (p=0,031) and 3 months
functional outcome; between intraoperative blood loss (p=0,013) and mortality,
as well as SAP with mortality (p=0,009); between tumor that underwent extensive
soft tissue reconstruction procedure and complication (p=0,019).
Conclusion Megaprosthesis reconstruction in bone tumors gives a good and
excellent result, which provides orthopaedic oncologic surgeons a rationalization
to make a selective decision-making in tumor cases regardless its survival and
tumor type. Oncologic outcome as well gave out good result with low incidence of far metastasis and local recurrence.;Introduction Advancement in bone tumor management has elaborated surgeon?s
choice of treatment not merely sentenced the patients into a limb ablation.
Likewise, patients with bone tumors, regardless its malignant nature and limited
survival time, had an equal privileges to opt for LSS to experience a better quality
of life. In this study, we manage to evaluate the functional and oncologic outcome
of lower extremity bone tumors following a LSS using megaprosthesis.
Methods Thirty-four patients with lower extremity bone tumors were
prospectively reviewed between 2011 and 2015 in a tertiary referral general
hospital. All patients were managed through a Clinical Pathology Conference.
Functional outcome was evaluated using MSTS score and follow up was recorded
at 3, 6, 12 months; and 2, 3, 4 years.
Results Two orthopedic musculoskeletal oncologic surgeons were performing the
surgeries. Two patients were excluded because the final instruments used were
not a modular type. The final result of functional score was good to excellent with
67.9% good at 6 months, 79,2% good at 9 months, 63.4% excellent at 12 months,
90% excellent at 24 months and 100% excellent at 36 months. Complications
occurred and varied. A statistical significant result was found between age
(p=0,001), age (p=0,039), gender (p=0,049), SAP (p=0,031) and 3 months
functional outcome; between intraoperative blood loss (p=0,013) and mortality,
as well as SAP with mortality (p=0,009); between tumor that underwent extensive
soft tissue reconstruction procedure and complication (p=0,019).
Conclusion Megaprosthesis reconstruction in bone tumors gives a good and
excellent result, which provides orthopaedic oncologic surgeons a rationalization
to make a selective decision-making in tumor cases regardless its survival and
tumor type. Oncologic outcome as well gave out good result with low incidence of far metastasis and local recurrence.;Introduction Advancement in bone tumor management has elaborated surgeon?s
choice of treatment not merely sentenced the patients into a limb ablation.
Likewise, patients with bone tumors, regardless its malignant nature and limited
survival time, had an equal privileges to opt for LSS to experience a better quality
of life. In this study, we manage to evaluate the functional and oncologic outcome
of lower extremity bone tumors following a LSS using megaprosthesis.
Methods Thirty-four patients with lower extremity bone tumors were
prospectively reviewed between 2011 and 2015 in a tertiary referral general
hospital. All patients were managed through a Clinical Pathology Conference.
Functional outcome was evaluated using MSTS score and follow up was recorded
at 3, 6, 12 months; and 2, 3, 4 years.
Results Two orthopedic musculoskeletal oncologic surgeons were performing the
surgeries. Two patients were excluded because the final instruments used were
not a modular type. The final result of functional score was good to excellent with
67.9% good at 6 months, 79,2% good at 9 months, 63.4% excellent at 12 months,
90% excellent at 24 months and 100% excellent at 36 months. Complications
occurred and varied. A statistical significant result was found between age
(p=0,001), age (p=0,039), gender (p=0,049), SAP (p=0,031) and 3 months
functional outcome; between intraoperative blood loss (p=0,013) and mortality,
as well as SAP with mortality (p=0,009); between tumor that underwent extensive
soft tissue reconstruction procedure and complication (p=0,019).
Conclusion Megaprosthesis reconstruction in bone tumors gives a good and
excellent result, which provides orthopaedic oncologic surgeons a rationalization
to make a selective decision-making in tumor cases regardless its survival and
tumor type. Oncologic outcome as well gave out good result with low incidence of far metastasis and local recurrence.;Introduction Advancement in bone tumor management has elaborated surgeon?s
choice of treatment not merely sentenced the patients into a limb ablation.
Likewise, patients with bone tumors, regardless its malignant nature and limited
survival time, had an equal privileges to opt for LSS to experience a better quality
of life. In this study, we manage to evaluate the functional and oncologic outcome
of lower extremity bone tumors following a LSS using megaprosthesis.
Methods Thirty-four patients with lower extremity bone tumors were
prospectively reviewed between 2011 and 2015 in a tertiary referral general
hospital. All patients were managed through a Clinical Pathology Conference.
Functional outcome was evaluated using MSTS score and follow up was recorded
at 3, 6, 12 months; and 2, 3, 4 years.
Results Two orthopedic musculoskeletal oncologic surgeons were performing the
surgeries. Two patients were excluded because the final instruments used were
not a modular type. The final result of functional score was good to excellent with
67.9% good at 6 months, 79,2% good at 9 months, 63.4% excellent at 12 months,
90% excellent at 24 months and 100% excellent at 36 months. Complications
occurred and varied. A statistical significant result was found between age
(p=0,001), age (p=0,039), gender (p=0,049), SAP (p=0,031) and 3 months
functional outcome; between intraoperative blood loss (p=0,013) and mortality,
as well as SAP with mortality (p=0,009); between tumor that underwent extensive
soft tissue reconstruction procedure and complication (p=0,019).
Conclusion Megaprosthesis reconstruction in bone tumors gives a good and
excellent result, which provides orthopaedic oncologic surgeons a rationalization
to make a selective decision-making in tumor cases regardless its survival and
tumor type. Oncologic outcome as well gave out good result with low incidence of far metastasis and local recurrence."
Fakultas Kedokteran Universitas Indonesia, 2015
SP-PDF
UI - Tugas Akhir  Universitas Indonesia Library
cover
Muhammad Dedy Alkarni
"Pendahuluan: Osteosarkoma adalah tumor tulang ganas primer pada anak-anak dan remaja. Penelitian ini bertujuan untuk membandingkan hasil dan kelangsungan hidup pada pasien osteosarkoma pasca operasi di RSCM Jakarta dari tahun 2010 hingga 2022 dan faktor-faktor yang mempengaruhinya.
Metode: Penelitian ini merupakan penelitian kohort retrospektif dilakukan di Rumah Sakit Cipto Mangunkusumo (RSCM). Subjek adalah pasien osteosarkoma femoralis distal yang menjalani disartikulasi pinggul atau amputasi transfemoral pada 2010-2020. Data yang dikumpulkan dan dianalisis meliputi karakteristik pasien, kelangsungan hidup, metastasis dan skor MSTS.
Hasil: Jumlah subjek penelitian adalah 42. Subjek amputasi transfemoral lebih tua dibandingkan disartikulasi pinggul (p=0,048). Insiden metastasis lebih banyak pada amputasi dibandingkan dengan disartikulasi pinggul (p=0,001). Subjek disartikulasi pinggul memiliki diameter tumor yang jauh lebih besar daripada subjek amputasi transfemoral (p=0,031).
Pembahasan: Hubungan yang signifikan antara diameter tumor dan kelangsungan hidup terjadi karena diameter tumor terkait dengan kejadian metastasis  dan kejadian metastasis terkait dengan kelangsungan hidup. Tidak ada perbedaan yang signifikan antara skor MSTS dan jenis amputasi karena kedua kelompok subjek menggunakan kruk, faktor sosial ekonomi untuk membuat prostesis, dan kesulitan dalam mencapai ukuran tunggul yang ideal dalam kasus tumor.
Kesimpulan: Ada hubungan yang signifikan antara diameter tumor dan metastasis dengan kelangsungan hidup dan diameter tumor dengan metastasis.

Pendahuluan: Osteosarkoma adalah tumor tulang ganas primer pada anak-anak dan remaja. Penelitian ini bertujuan untuk membandingkan hasil dan kelangsungan hidup pada pasien osteosarkoma pasca operasi di RSCM Jakarta dari tahun 2010 hingga 2022 dan faktor-faktor yang mempengaruhinya.
Metode: Penelitian ini merupakan penelitian kohort retrospektif dilakukan di Rumah Sakit Cipto Mangunkusumo (RSCM). Subjek adalah pasien osteosarkoma femoralis distal yang menjalani disartikulasi pinggul atau amputasi transfemoral pada 2010-2020. Data yang dikumpulkan dan dianalisis meliputi karakteristik pasien, kelangsungan hidup, metastasis dan skor MSTS.
Hasil: Jumlah subjek penelitian adalah 42. Subjek amputasi transfemoral lebih tua dibandingkan disartikulasi pinggul (p=0,048). Insiden metastasis lebih banyak pada amputasi dibandingkan dengan disartikulasi pinggul (p=0,001). Subjek disartikulasi pinggul memiliki diameter tumor yang jauh lebih besar daripada subjek amputasi transfemoral (p=0,031).
Pembahasan: Hubungan yang signifikan antara diameter tumor dan kelangsungan hidup terjadi karena diameter tumor terkait dengan kejadian metastasis dan kejadian metastasis terkait dengan kelangsungan hidup. Tidak ada perbedaan yang signifikan antara skor MSTS dan jenis amputasi karena kedua kelompok subjek menggunakan kruk, faktor sosial ekonomi untuk membuat prostesis, dan kesulitan dalam mencapai ukuran tunggul yang ideal dalam kasus tumor.
Kesimpulan: Ada hubungan yang signifikan antara diameter tumor dan metastasis dengan kelangsungan hidup dan diameter tumor dengan metastasis.
"
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2022
SP-pdf
UI - Tugas Akhir  Universitas Indonesia Library
cover
Mursid Fadli
"ABSTRAK
Pendahuluan
Acute limb ischemia (ALI) adalah kondisi serius yang ditandai dengan penurunan
yang cepat dan mendadak dari perfusi tungkai. 1 Di Amerika Serikat insiden Acute leg
ischemia diperkirakan terjadi 14 per 100.000 penduduk per tahun, sedangkan Acute
arm ischemia seperlimanya. Penyebab utama dari Acute limb ischemia ini lebih dari
90 % adalah thromboemboli. 2 Acute limb ischemia merupakan salah satu tantangan
terberat, penilaian awal dan assestment penting, karena kesalahan diagnosis dapat
mengakibatkan amputasi pada pasien atau bahkan kematian.
Metode
Jenis penelitian ini adalah deskriptif retrospektif. Dilakukan di Rumah Sakit Cipto
Mangunkusumo (RSCM), dengan mengumpulkan data rekam medis pada pasienpasien
dengan ALI di divisi Vaskuler dan Endovaskuler periode 1 Januari 2009 – 31
Desember 2011. Kriteria inklusi meliputi semua pasien ALI yang sudah didiagnosis
secara pasti dan dilakukan tindakan operasi. Kriteria eksklusi meliputi pasien ALI
yang tidak memiliki data rekam medis lengkap.
Hasil
Dari 32 kasus ALI yang dirawat di Divisi Vaskuler dan Endovaskuler, didapatkan 22
kasus (69 %) laki-laki dan 10 kasus (31 %) perempuan. Usia terbanyak pada
kelompok umur 40 – 60 tahun sebanyak 17 kasus (53 %). Untuk penyebab ALI yang
paling sering yaitu thrombus sebanyak 19 pasien (59 %). Faktor resiko yang paling
sering adalah pasien dengan atherosklerosis sebanyak 18 pasien. Sebanyak 16 pasien
(50 %) datang ke RS sudah masuk dalam klasifikasi III ALI. Sebanyak 26 pasien (81
%) terkena pada ekstremitas bawah dan sebanyak 6 pasien (19 %) terkena pada
ekstremitas atas. Dari data didapatkan 3 pasien yang meninggal.
Kesimpulan
Manajemen terhadap ALI tetap menjadi tantangan, karena melibatkan salah satu
jalur keputusan yang paling kompleks dalam operasi vaskuler. Pasien dengan kondisi
Acute limb ischemia, sebaiknya dirujuk ke pusat vaskular tanpa di tunda-tunda.

ABSTRACT
Background
Acute limb ischemia (ALI) is a serious condition characterized by rapid and sudden
limb perfusion. In the United States the incidence of acute leg ischemia is thought to
be 14 per 100,000 population per year, while one-fifth of acute arm ischemia. The
main cause of acute limb ischemia is more than 90% are thromboemboli. Acute limb
ischemia is one of the toughest challenges, initial assessment important, because
misdiagnosis can lead to amputation or even death in patients.
Method
The study was a retrospective descriptive. The study was conducted in Cipto
Mangunkusumo Hospital (RSCM), by collecting data from medical records of
patients with ALI in Vascular and Endovascular Surgery division from 1st January
2009 through 31st December 2011. Inclusion criteria include all ALI patients already
diagnosed with certainty and performed surgery. Exclusion criteria include patients
with ALI who did not have complete medical records.
Result
Of the 32 cases of ALI, 22 cases were found in men and 10 cases were found in
women. Age of majority in the age group 40-60 years 17 cases. For the most frequent
cause of ALI is thrombus were 19 patients. The most frequent risk factors were as
many as 18 patients with atherosclerotic patients. A total of 16 patients came to the
hospital already in the classification III of ALI. A total of 26 patients affected the
lower extremities and 6 patients affected the upper extremities. Three patients died.
Conclusion
Management of the ALI remains a challenge, as it involves one of the most complex
decisions pathways in vascular surgery. Patients with acute limb ischemia conditions,
should be referred to a vascular center without delay delay."
Fakultas Kedokteran Universitas Indonesia, 2012
T32125
UI - Tesis Membership  Universitas Indonesia Library
cover
Bayu Agung Alamsyah
"Latar Belakang: Chronic limb threatening ischemia (CLTI) merupakan bentuk paling parah dari peripheral arterial disease (PAD). Sebanyak 25% pasien CLTI memiliki risiko amputasi tungkai mayor dan 25% lainnya akan meninggal karena penyakit kardiovaskular dalam 1 tahun. Risiko amputasi ini dapat diprediksi menggunakan sistem skoring Wound, Ischemia, and foot Infection (WIfI). Penelitian ini bertujuan untuk mendapatkan profil amputasi menggunakan skor Wound, Ischemia, foot Infection pada subjek chronic limb threatening ischemia di Rumah Sakit dr. Cipto Mangunkusumo (RSCM).
Metode: Pengambilan data retrospektif dari data registrasi divisi bedah vaskular dan rekam medis pada subjek dengan CLTI di RSCM berupa profil subjek, skor WIfI, dan status amputasi mayor dalam 1 tahun pasca diagnosis CLTI ditegakkan. Data selanjutnya dimasukkan ke program SPSS, dan dilakukan analisa data. Hasil analisa lalu dipaparkan dalam bentuk narasi dan tabel.
Hasil: Pada penelitian ini usia rerata subjek adalah 58,1 ± 12,9 tahun dengan predominasi jenis kelamin laki-laki (58,3%). Komorbid pada subjek dari yang tersering adalah diabetes (82,1%), hipertensi (67,9%), gagal ginjal kronis (51,3%), dan penyakit jantung (33%). Derajat skor WIfI dengan derajat sangat rendah, rendah, sedang, dan tinggi secara berurutan adalah 6,4%, 9,6%, 35,9%, dan 48,1%. Angka amputasi mayor yang sesungguhnya pada subjek CLTI di RSCM untuk skor WIfI derajat sangat rendah, rendah, sedang, dan tinggi adalah 5%, 7%, 35%, dan 70%, sedangkan pada kepustakaan adalah 3%, 8%, 25%, dan 50%.

Background: Chronic limb threatening ischemia (CLTI) is the most severe form of peripheral arterial disease (PAD). As many as 25% of CLTI patients have a risk of major limb amputations and 25% will die due to cardiovascular event within 1 year. The risk of this major amputation can be predicted using the Wound, Ischemia, and foot Infection (WIfI) scoring system. This study aims to compare the amputation profile using Wound, Ischemia, foot Infection scores in chronic limb threatening ischemia patients at the RSCM.
Methods: Retrospective data collection from registry in vascular surgery division and medical records for patients with CLTI in RSCM were take, that is a patient profile, the comorbid disease, WIfI score, and the patient's major amputation status within 1 year after diagnosis of CLTI was established. The data then inputed to the SPSS program, and data analysis is performed. The results of the analysis are then presented in the form of narratives and tables.
Result: The mean age of the subjects in this study was 58,1 ± 12,9 years with male as gender predominance (58,3%). The comorbids in the subjects were diabetes (82,1%), hypertension (67,9%), chronic kidney failure (51,3%), heart disease (33%). The WIfI scores with very low, low, medium, and high degrees are 6,4%, 9,6%, 35,9%, and 48,1% respectively. The major amputation rates in for WIfI scores with very low, low, medium, and high degrees are 5%, 7%, 35%, and 70%, while in the literature are 3%, 8%, 25%, and 50%.
"
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2019
T58708
UI - Tesis Membership  Universitas Indonesia Library
cover
Kevin Triangto
"Osteosarkoma digolongkan sebagai salah satu keganasan tersering pada usia remaja dan dewasa muda. Sampai saat ini, angka kesintasan osteosarkoma di Indonesia masih rendah. Penelitian sebelumnya menyatakan bahwa angka kesintasan bergantung pada diagnosis histopatologik. Selain itu, telah ditemukan sebuah pola insidens umum yang berhubungan dengan usia, jenis kelamin, dan lokasi tumor. Maka itu, penelitian ini dilakukan untuk membuktikan adanya hubungan antara usia dan lokasi tumor, juga untuk mengetahui profil osteosarkoma di Rumah Sakit Cipto Mangunkusumo pada tahun 2006-2011.
Desain penelitian ini adalah potong lintang, dan data diperoleh dari departemen Patologi Anatomi Rumah Sakit Cipto Mangunkusumo sebanyak 187 kasus osteosarkoma. Uji chi-square telah digunakan untuk menganalisis hubungan.
Dari hasil penelitian ini, ditemukan mayoritas pasien adalah laki-laki (58.8%) dan kebanyakan berusia remaja dan dewasa muda (61%). Predileksi tersering adalah bagian tulang panjang ekstremitas bawah (54.3%), telah ditemukan hubungan yang bermakna dengan usia remaja dan dewasa muda (p = 0.018). Selain itu, diagnosis yang tersering ditemukan adalah osteosarkoma konvensional sebanyak 93% dari populasi sampel.
Kesimpulan yang bisa diambil adalah pasien remaja memiliki kemungkinan dua kali lipat lebih tinggi untuk terkena osteosarkoma pada tulang panjang, disebabkan adanya keterlibatan dari lempeng pertumbuhan di tulang.

Osteosarcoma had been classified as one of the most common malignancy in the adolescents. Until recently, osteosarcoma survival rate in Indonesia is still considered low. Previous studies mentioned that survival rates are dependent on histopathologic diagnosis. Interestingly, a common incidence pattern was found and was associated to age, gender and sites. Therefore, this study was meant to describe the association between predilection site and age, as well as presenting the profile of osteosarcoma in Cipto Mangunkusumo hospital in 2006-2011.
This cross-sectional study took place in the Department of Anatomical Pathology Cipto Mangunkusumo hospital, where 187 osteosarcoma cases were found. Chisquare test was used to analyze the association.
It was revealed in the results that the sample was predominated by males (58.8%), and majority of the cases were adolescents (61%), The most common site affected is long bones of the lower extremities (54.3%), and this was found to be associated with the incidence in adolescents (p = 0.018). Accordingly, the most common diagnosis found was conventional osteosarcoma, accounting for 93% of the sample.
In conclusion, adolescent patients were found to be roughly two times more likely to develop conventional osteosarcoma on long bones, suggesting possible growth plate involvement.
"
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2013
S-Pdf
UI - Skripsi Membership  Universitas Indonesia Library
cover
Budhi Arifin Noor
"Latar belakang: Chronic limb threatening ischemia (CLTI) merupakan bentuk terparah peripheral arterial disease. Pasien kaki diabetik dengan CLTI memiliki risiko amputasi mayor dan mortalitas paska revaskularisasi dan dipengaruhi beberapa faktor seperti usia lanjut, gagal ginjal kronik, komorbid penyakit jantung dan hipertensi. Indonesia belum memiliki data amputasi mayor dan mortalitas kaki diabetik dengan CLTI setelah revaskularisasi dan faktor-faktor yang berpengaruh. Penelitian ini bertujuan mengetahui angka amputasi mayor dan mortalitas satu tahun pasca revaskularisasi beserta faktor-faktor yang memengaruhi di Rumah Sakit Cipto Mangunkusumo (RSCM).
Metode: Kohort retrospektif pasien kaki diabetik dengan CLTI setelah revaskularisasi di RSCM Januari 2010 – Desember 2020. Pengambilan data rekam medis. Luaran utama amputasi mayor dan mortalitas satu tahun setelah revaskularisasi. Dilakukan analisis bivariat dengan uji Kai Kuadrat, jika persyaratan tidak terpenuhi maka menggunakan Fischer-exact, variabel bermakna diuji lebih lanjut dengan regresi logistik.
Hasil: Penelitian melibatkan 150 subjek. Amputasi mayor dan mortalitas satu tahun setelah revaskularisasi sebesar 27,3% dan 24,7%. Tidak didapatkan hubungan yang bermakna antara faktor-faktor yang diteliti dengan amputasi mayor dan mortalitas satu tahun.
Kesimpulan: Didapatkan angka amputasi mayor dan mortalitas 1 tahun pasca revaskularisasi. Usia lanjut, gagal ginjal kronik, komorbid penyakit jantung dan hipertensi bukan merupakan faktor yang memengaruhi angka amputasi dan mortalitas satu tahun.

Background: Chronic limb threatening ischemia (CLTI) is the most severe form of peripheral arterial disease. Diabetic foot patients with CLTI have major amputation and mortality risk after revascularization and affected by factors such as elderly, chronic kidney disease (CKD), cardiac morbidity and hypertension. In Indonesia there are no data regarding diabetic foot major amputation and mortality with CLTI after revacularization and influencing factors. Study aims to determine one year major amputation and mortality and factors that can affect diabetic foot pastients with CLTI after revascularization.
Methods: Retrospective cohort study on diabetic foot patients with CLTI undergoing revascularization at Cipto Mangunkusumo National Hospital from January 2010 to December 2020. The primary outcome was one-year major amputation and mortality after revascularization. Factors included were age, CKD, cardiac comorbidity and hypertension. We conducted bivariate analysis using Chi Square or Fisher-exact test. Variables were further tested using multivariate test.
Result: 150 subjects were enrolled. One-year major amputation and mortality was 27.3% and 24.7%. There are not significant correlations between factors with major amputation and mortality.
Conclusion: Major amputation and mortality rate one year after revascularization at RSCM are gained. Elderly, CKD, cardiac comorbidity and hypertension are not factors affecting one-year major amputation and mortality.
"
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2021
UI - Tugas Akhir  Universitas Indonesia Library
cover
Husnul Verdian
"Latar Belakang: Osteosarkoma merupakan jenis tumor tulang ganas paling sering pada anak dan remaja. Sejumlah faktor prognostik telah diketahui mempengaruhi luaran pada osteosarkoma pediatrik, termasuk lokasi dan ukuran tumor primer, adanya metastasis, resektabilitas, keadaan remisi, serta respons kemoterapi yang diperiksa dengan derajat nekrosis tumor. Penelitian ini bertujuan untuk mengetahui luaran osteosarkoma pada anak dan faktor-faktor yang mempengaruhinya.
Metode: Penelitian ini merupakan studi observasional dengan desain cross sectional. Penelitian dilakukan di poliklinik Onkologi Orthopaedi Rumah Sakit Cipto Mangunkusumo, Jakarta pada bulan Januari 2020-Juni 2021. Pengambilan subjek penelitian dilakukan berdasarkan metode consecutive sampling. Data klinis, radiologis dan laboratorium diambil dari rekam medis, sementara skor MSTS diukur melalui wawancara terhadap subjek baik secara langsung atau pun melalui telepon. Data pasien dimasukkan ke dalam CRF (Case Report Form) untuk osteosarkoma dari Departemen Orthopaedi dan Traumatologi. Seluruh data dianalisis dan ditabulasikan ke dalam tabel.
Hasil dan pembahasan: Pada penelitian ini, angka kesintasan keseluruhnan kasus osteosarkoma adalah 31,8%, dan rekurensi lokal terjadi pada 18,2% kasus pasien osteosarkoma anak. Metastasis terjadi pada 65,9% kasus dan sebagain besar metastasis ditemukan pada paru. Didapatkan jenis kelamin berhubungan dengan kesintasan pada pasien osteosarkoma (P<0,05). Hubungan kesintasan dengan usia sampel tidak bermakna, namun terdapat hubungan signifikan antara kesintasan dengan alkalin fosfatase, jenis biopsi, lokasi tumor, dan tipe HUVOS. Terdapat hubungan signifikan antara rekurensi lokal dengan nilai serum alkaline fosfatase, namun tidak terdapat hubungan signifikan antara rekurensi lokal jenis kelamin dan usia, jenis biopsi, tipe HUVOS, dan lokasi tumor. Rata-rata skor MSTS dari 14 subjek penelitian adalah 20,93 ± 3,63. Tidak terdapat perbedaan signifikan antara metastasis dengan jenis kelamin, usia, alkalin fosfatase, jenis biopsi, tipe HUVOS, dan lokasi tumor. Terdapat hubungan signifikan antara rekurensi lokal dan alkaline fosfatase (P < 0,05). Kesintasan dan metastasis memiliki perbedaan yang signifikan (P < 0,001).
Kesimpulan: Terdapat hubungan yang bermakna antara kadar alkaline fosfatase terhadap rekurensi lokal pada anak dengan osteosarkoma. Terdapat hubungan yang bermakna antara metastasis dengan kesintasan 5 tahun pada anak dengan osteosarkoma. Hal ini menandakan bahwa angka kesintasan tinggi pada pasien yang tidak mengalami metastasis.

Background: Osteosarcoma is the most frequent malignant bone tumor in children and adolescents. A number of prognostic factors have been known to affect the outcomes of pediatric osteosarcoma, including the location and size of the primary tumor, the presence of metastasis, resectability, remissions, and the chemotherapy response examined by the degree of tumor necrosis. This study aims to determine the outcomes of osteosaroma in children and the factors that influence it.
Methods: This was an observational analytic study with a retrospective cross sectional design. The study was conducted at the Orthopedic Oncology Polyclinic Cipto Mangunkusumo Hospital, Jakarta in January 2020 – June 2021. The research sampling was carried out based on the consecutive random sampling method. Clinical, radiological and laboratory data were documented from medical records, while the MSTS score was measured through interviews on the subject both directly or by telephone. Patient data was inserted into the CRF (Case Report Form) for osteosarcoma from the orthopedic and traumatology department. All data were analysed and tabulated into the table.
Results and Discussion: In this study, the overall 5 years survival rate of osteosarcoma was 31.8%, and the local recurrence is 18.2% of pediatric osteosarcoma patients. Metastases occurred in 65.9% of cases and most of the metastases were found in the lung. It was found that gender was significanced with survival in osteosarcoma patients (P<0.05). The relationship between survival and age was not significant, but there was a significant relationship between survival and alkaline phosphatase, type of biopsy, tumor location, and type of HUVOS. There was a significant relationship between local recurrence and serum alkaline phosphatase, but there was no significant relationship between local recurrence, gender and age, type of biopsy, HUVOS type, and tumor location. The mean of MSTS score of the 14 study subjects was 20.93 ± 3.63. There was no significant difference between metastases by sex, age, alkaline phosphatase, type of biopsy, type of HUVOS, and tumor location. There was a significant relationship between local recurrence and alkaline phosphatase (P < 0.05). There was a significant difference between survival and metastasis (P < 0.001).
Conclusion: There was a significant relationship between alkaline phosphatase level and local recurrence in children with osteosarcoma. There was a significant association between metastasis and a 5-year mortality in children with osteosarcoma
"
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2021
SP-pdf
UI - Tugas Akhir  Universitas Indonesia Library
cover
Manurung, Mikhael Dito
"Walaupun masih kontroversial, jenis kelamin dan umur diduga sebagai faktor prognostik yang mempengaruhi angka kesintasan osteosarkoma (suatu keganasan tulang yang umum terjadi pada anak-anak dan dewasa muda). Oleh karena itu, penelitian ini bertujuan untuk mengetahui angka kesintasan pasien osteosarkoma di RSCM selama periode waktu enam tahun (2006-2011) dan mengaitkannya dengan umur dan jenis kelamin. Studi potong-lintang ini menggunakan rekam medis 167 pasien osteosarkoma di Departemen Ortopedi dan Traumatologi Rumah Sakit Cipto Mangunkusumo (RSCM).
Studi ini menunjukkan bahwa usia lebih muda saat didiagnosis berkaitan dengan respon yang lebih baik terhadap kemoterapi (p=0,028). Jenis kelamin perempuan berkaitan secara signifikan dengan stadium penyakit yang lebih rendah (p=0,04), respon yang lebih baik terhadap kemoterapi (p=0,016), dan berkurangnya risiko metastasis (p=0,008). Median waktu kesintasan pada studi ini adalah 12 bulan, yang disebabkan oleh pendeknya masa pemantauan pasien. Walaupun terdapat keterbatasan, angka kesintasan pasien perempuan lebih baik secara signifikan daripada pasien laki-laki. Angka kesintasan pada golongan usia yang lebih muda menunjukkan kecenderungan lebih baik, walau tidak signifikan secara statistik. Hasil uji multivariate tidak menunjukkan bukti tentang adanya keterkaitan stadium penyakit, respon kemoterapi, dan metastasis terhadap kesintasan. Sebagai kesimpulan, jenis kelamin perempuan berkaitan dengan tumor yang lebih favourable dan angka kesintasan yang lebih tinggi.

In order to improve the plateaued average 70% survival of osteosarcoma patients, prognostic factors has to be identified to improve adjustment according to patient's characteristics. Female gender and younger age at diagnosis have been suggested as good prognostic factors though inconclusive. Therefore, this study aims to determine the survival rate of osteosarcoma patients admitted to Cipto Mangunkusumo Hospital from 2006 to 2011 and correlate it with age and gender. This cross-sectional study used the medical records of osteosarcoma patients admitted in the department of Orthopedics and Traumatology Cipto Mangunkusumo Hospital. Records of 167 patients were retrieved for this study.
This study shown that younger age was associated with better chemotherapeutic response (p=0,028). Meanwhile, female gender was associated with less advanced disease at presentation (p=0,04), better chemotherapeutic response (p=0,016), and less risk for metastasis (p=0,008). The median survival in this study was 12 months, an underestimation due to short followup duration. Still, female patients survived longer than males. We showed a trend of better survival for younger patients, however the result was not significant. Multivariate analysis failed to show any correlation between various tumor-related variables with survival.
"
Jakarta: Fakultas Kedokteraan Universitas Indonesia, 2013
S-Pdf
UI - Skripsi Membership  Universitas Indonesia Library
cover
Reki Setiawan
"Berdasarkan pengalaman Departemen Bedah Saraf Fakultas Kedokteran Universitas Indonesia – Rumah Sakit Cipto Mangunkusumo (FKUI-RSCM), pasien datang berobat dengan durasi keluhan yang beragam untuk suatu diagnosis adenoma hipofisis. Sebagai rumah sakit pusat rujukan nasional, semua pasien adenoma hipofisis yang datang ke institusi kami merupakan pasien rujukan dari dokter spesialis mata, spesialis saraf, maupun dokter spesialis bedah saraf dari institusi lain. Adenoma hipofisis dapat menyebabkan keluhan visus, lapang pandang, dan keluhan-keluhan lain yang diakibatkan oleh gangguan hormonal. Beberapa penelitian telah menyatakan hubungan antara durasi keluhan dengan luaran klinis dengan hasil yang signifikan. Pada penelitian ini akan dicari hubungan antara durasi, yang dihitung mulai dari awal keluhan sampai dilakukan tindakan operasi, dengan luaran visus dan lapang pandang pada pasien adenoma hipofisis yang dilakukan operasi dengan pendekatan transnasal transfenoid.
Penelitian ini merupakan penelitian restrospektif pada pasien adenoma hipofisis yang dilakukan tindakan operasi dengan pendekatan transnasal transfenoid antara tahun 2015-2017. Seluruh operasi dilakukan oleh spesialis bedah saraf di RSCM. Semua pasien pada penelitian ini mengalami penurunan visus dan penyempitan lapang pandang. Durasi antara onset sampai dengan dilakukan tindakan operasi dihitung dalam satuan bulan. Dilakukan pemeriksaan visus dan lapang pandang 1 hari sebelum operasi dan dalam 1 sampai 2 bulan pasca operasi. Penelitian ini juga menghitung volume tumor, presentase tumor yang diambil, dan perluasan tumor, tetapi tidak dapat dilakukan uji statistik karena dibutuhkan jumlah sampel yang lebih banyak.
Tujuh puluh satu pasien dengan keluhan penurunan visus dan penyempitan lapang pandang dengan median usia 42 tahun (20-77 tahun). Terdapat 36 pasien berjenis kelamin laki-laki dan 35 pasien perempuan. Median durasi mulai dari onset sampai dilakukan tindakan operasi untuk keluhan penurunan visus dan penyempitan lapang pandang adalah sama yaitu 12 bulan (1-108 bulan). Tedapat perbaikan visus pasca operasi pada 50 pasien (40,5%), dengan median durasi onset sampai dilakukan tindakan operasi adalah 11 bulan (p=0,58). Pada pasien keluhan penyempitan lapang pandang didapatkan perbaikan klinis pada 48 pasien (67.6%), dengan median durasi onset sampai dilakukan tindakan adalah 12 bulan (p=0.01).
Dari penelitian ini dapat ditarik kesimpulan bahwa terdapat hubungan bermakna secara statistik antara durasi onset sampai dilakukan tindakan operasi dengan luaran klinis lapang pandang. Perbaikan lapang pandang didapatkan pada pasien yang memiliki durasi onset sampai dilakukan tindakan operasi sampai dengan 12 bulan.

Based on the experience of the Department of Neurosurgery, Faculty of Medicine, Universitas Indonesia-Cipto Mangunkusumo Hospital (FMUI-Cipto Mangunkusumo Hospital), patients came seeking treatment with varying duration of complaints for a diagnosis of pituitary adenoma. As a national referral center hospital, all pituitary adenoma patients who came to our institution were referred from ophthalmologists, neurologists, and neurosurgeons from other institutions. Pituitary adenomas can cause decrease of visual acuity (VA), narrowing visual field (VF), and other complaints caused by hormonal disorders.1 Several studies have showed that the duration of complaints were related significantly with clinical outcomes.2,3,4,5,6
In this study, we investigated the relationship between duration, which is calculated from the time of symptoms first appeared to the time of surgery, and outcome (visual field and visual acuity) in pituitary adenoma patients who underwent surgery via transnasal-transsphenoidal approach.
This study used retrospective design on pituitary adenoma patients who was performed surgery via transnasal-transsphenoidal approach between 2015-2017. All surgeries were performed by neurosurgeons at RSCM. All patients in this study experienced decreased VA and narrowing of the VF. The duration between symptoms’ onset and surgery was calculated in months. VA and VF examinations were performed 1 day before surgery and within 1 to 2 months postoperatively. This study also calculated the volume of tumor, the percentage of tumor removal, and the extent of tumor, but statistical tests cannot be carried out on these parameters because more samples are needed.
There were 71 patients with decreased visual acuity and narrowed visual field, consisted of 36 male and 35 female patients, with a median age of 42 years (20-77 years). The median length of duration of onset for both symptoms is the same, which was 12 months (1-108 months).
Fifty patients (40.5%) had improved VA postoperatively, with median duration of onset was 11 months (p = 0.58). Clinical improvement in VF was experienced in 48 patients (67.6%), in which the median duration of onset was 12 months (p = 0.01)
There was a statistically significant relationship between the duration of onset and the VF outcomes. Improvements in the VF were found in patients who underwent surgery up to 12 months after the time of onset.
"
Depok: Fakultas Kedokteran Universitas Indonesia, 2020
T-pdf
UI - Tesis Membership  Universitas Indonesia Library
<<   1 2 3 4 5 6 7 8 9 10   >>